Lonza | Competitive Intelligence Profile
Lonza is a global contract development and manufacturing organization (CDMO) founded in Switzerland in 1897, specializing in pharmaceutical,...
Lonza is a global contract development and manufacturing organization (CDMO) founded in Switzerland in 1897, specializing in pharmaceutical, biotech, and nutrition sectors. It provides end-to-end services including custom manufacturing of biologics, small molecules, cell and gene therapies, and capsules, leveraging cutting-edge science and technology to help bring life-enhancing treatments to market. With around 18,500 employees across five continents, Lonza is a pioneer in the CDMO industry, focusing on quality, safety, and reliability.
🛍️ Lonza Product and Pricing Intelligence →
📅 Lonza Event Participations →
⚖️ Lonza Regulatory Intelligence →
👔 Lonza Management and Leadership Team →
⚔️ Lonza Alternatives and Competitors →
💼 Lonza Hiring and Layoffs →
🤝 Lonza Partnerships, Clients and Vendors →
📈 Lonza Financial Performance, Fundraising, M&A →
🛍️ Lonza Product and Pricing Intelligence
Leverage product insights to define key product development milestones, guide go-to-market planning, build a robust product-market fit matrix, and perform in-depth SWOT analyses.
Harness pricing intelligence to support strategic pricing decisions, conduct competitive pricing analysis, and craft effective differential pricing strategies.
- Lonza Capsugel team unveiled Organicaps, the only USDA organic-certified pullulan capsules made in North America, at SupplySide Global 2025.
- Lonza Capsules & Health Ingredients will showcase new products including UC-II® for joint health, product development services, and USDA Organic certified Organicaps™ capsules at its booth 5665 during SupplySide Global 2025.
📅 Lonza Event Participations
Stay updated on where your competitors are showing up—industry conferences, webinars, podcasts, and speaking engagements—to gauge their messaging, target audiences, and strategic focus. Discover how they’re positioning themselves in the market, what narratives they’re pushing, and which partnerships they’re cultivating. Use this intelligence to refine your own positioning, identify missed opportunities, and stay top-of-mind in your industry.
- Lonza will exhibit at CPHI 2025 in Frankfurt.
- Lonza will showcase its innovation services and capsule technologies at the CPhI Worldwide fair in Frankfurt from October 28-30, 2025.
- Lonza is participating in BIO Europe Fall 2025 from November 3-5.
⚖️ Lonza Regulatory Intelligence
Monitor critical regulatory events—such as issued or revoked licenses, lawsuits, investigations, and court rulings—to understand the compliance posture and legal exposure of your rivals. Spot early warning signs of operational risk, delays, or reputational damage, and use these insights to fine-tune your market strategy, mitigate your own risk, or capitalize on competitor setbacks.
👔 Lonza Management and Leadership Team
Understand who’s steering your competitors by tracking changes in their management and leadership teams. Gain insights into strategic direction, leadership style, and organizational priorities based on executive backgrounds and hiring trends. Use this knowledge to anticipate competitive moves, tailor your sales or partnership approach, and benchmark against industry leaders.
-
Group Chief Financial Officer
[email protected] -
Chief Executive Officer[email protected]
-
Executive Director Manufacturing Operations[email protected]
-
Executive Director[email protected]
-
President, Integrated Biologics, Executive Committee Member[email protected]
-
Managing Director[email protected]
-
Vice President and CFO, Specialized Modalities[email protected]
-
Managing Director
-
Vice President, CFO Advanced Synthesis Business Platform[email protected]
-
Broker & CEO[email protected]
-
Group CEO[email protected]
-
Managing Director[email protected]
⚔️ Lonza Alternatives and Competitors
Identify the competitors of your competitors to uncover indirect threats, emerging disruptors, and untapped opportunities. Understand the broader competitive ecosystem, spot white space in the market, and gain strategic context that helps you position more effectively. These insights sharpen your market intelligence and reveal angles others often overlook.
- Recipharm |
- Catalent |
- RoosterBio |
- Nissan Chemical |
- Novozymes |
- WuXi Biologics |
- DuPont |
- Bristol Myers Squibb |
- DSM |
- Divis Laboratories |
- Kemin Industries |
- Siegfried |
- Cambrex Corporation |
- Stemcell Technologies |
- Amgen |
- BioReliance |
- Boehringer Ingelheim |
- Lanxess |
- Albemarle |
- Croda |
- Stepan |
- Tetratec |
- Glenncorp |
- Ulprospector |
- Pharmaron |
- Pfizer
💼 Lonza Hiring and Layoffs
Track key workforce changes—new hires, leadership shifts, and layoffs—to spot strategic organizational moves. Identify rising competitors, uncover shifts in company direction, and seize opportunities to attract top talent or engage new decision-makers. Use these insights to refine your recruitment strategy and build stronger business relationships.
- Himanshu Bindlish has joined Lonza as Director Finance - GBSO in India.
- Karsten Haas joined Lonza in Switzerland as Director QA Small & Mid-scale advanced synthesis, previously Head QA Operations - TRD Biologics at Novartis.
- Paulo Camossa has joined Lonza as Site Quality Head in the United States, previously serving as Director of Quality Operations at Alcami Corporation.
🤝 Lonza Partnerships, Clients and Vendors
Monitor new partnerships, client wins, and vendor relationships to understand where your competitors are gaining traction. Spot emerging alliances, evaluate ecosystem shifts, and identify potential partners or prospects early. These insights help you refine your sales strategy, anticipate market movements, and stay one step ahead in a dynamic competitive landscape.
- Lonza manufactured a first-in-class IgE antibody for Epsilogen Ltd's clinical trial to treat solid tumor cancers.
📈 Lonza Financial Performance, Fundraising, M&A
Track competitors’ financial performance, fundraising rounds, and M&A activity to assess their growth trajectory and strategic focus. Uncover signals of expansion, market entry, or consolidation, and benchmark your position accordingly. Use these insights to inform investor conversations, identify acquisition opportunities, and fine-tune your competitive strategy.
- Lonza acquires Redberry SAS to expand its rapid microbiology testing solutions using solid-phase cytometry technology.
- Lonza is acquiring Redberry SAS to strengthen its quality control testing with rapid microbial detection technology.
- Lonza confirms its annual growth forecasts after a strong third quarter driven by the integration of its Vacaville plant, new strategic contracts, and progress in its Swiss operations.
People also viewed
- Viralgen |
- Merck |
- Charles River Laboratories |
- Resilience |
- AGC Biologics |
- SK pharmteco |
- Andelyn Biosciences |
- SimplePractice |
- LG Ad Solutions |
- iSpot.tv |
- TherapyAppointment |
- Sessions Health
Ready to outsmart the competition? RivalSense cuts through the clutter of generic tools like Google Alerts, delivering laser-focused competitive intelligence without the noise. Track competitors’ every move—website changes, product updates, social media buzz, news mentions, and regulatory shifts—all in one sleek platform. Uncover pricing strategies, decode market trends, and gain actionable insights to fuel your business strategy. No more guesswork. Just power.
Join thousands of forward-thinking teams who trust RivalSense to automate their competitive monitoring and turn data into domination. Start your FREE trial today—no credit card needed—and see why staying ahead has never been this easy. Your competitors won’t know what hit them.
Outthink. Outpace. Outperform. #RivalSense